Segnalo questa nuova molecola di sicuro interesse nel futuro trattamento dei disordini dermatologici androgeno-dipendenti.
Clascoterone: First Approval - Drugs
Clascoterone (Winlevi®) is an androgen receptor inhibitor being developed as a topical cream and solution by Cassiopea (a spin-out company of Cosmo Pharmaceuticals) for the treatment of androgen-dependent skin disorders, including androgenetic alopecia and acne vulgaris. Although the exact...
link.springer.com